News

Strategies for Managing IV Fluid Supply Disruptions

Strategies for Managing IV Fluid Supply Disruptions

Understanding Potential Supply Disruptions for IV Fluids

In the face of possible supply disruptions caused by natural disasters, healthcare organizations must stay prepared. Recently, the impact of Hurricane Helene has brought attention to this issue, particularly concerning IV fluids. The North Cove facility operated by Baxter International, Inc. is a primary producer of large volume IV fluid bags vital for patient care across the country. With this situation at hand, Vizient has taken proactive measures to support healthcare providers dealing with potential IV fluid shortages.

Monitoring the Situation

John Thompson, a key figure at Vizient, highlighted the importance of ongoing assessment. "Vizient has been closely monitoring the situation since the storm hit and we are in communication with officials at Baxter as they assess the impact to the facility and their employees," he shared. Keeping in communication with facilities like Baxter is crucial for ensuring that healthcare providers receive the information they need to make informed decisions regarding their supplies.

Promoting Inventory Management

In light of these circumstances, healthcare systems are encouraged to take immediate corrective actions to manage inventory effectively. Strategies outlined by Vizient include evaluating IV fluid supplies on a broader health system level to prioritize areas with the greatest need. This systematic evaluation helps to ensure that critical care areas are stocked adequately while minimizing excess inventory in less essential areas.

Implementing Conservation Practices

Adopting conservation strategies is essential during supply shortages. Here are some recommendations:

  • Minimize the unit stock of large-volume IV bags wherever possible.
  • Stock smaller volume bags in other areas, especially pediatric wards.
  • Ensure that purchasing agents maintain active backorders to secure allocations as they become available.

Furthermore, Mittal Sutaria, a senior vice president at Vizient, emphasized the foundational role of IV fluids in medication delivery. "Conservation strategies will play a critical role in ensuring that patient care remains safe and effective," he stated. Providers now have access to a detailed guide that helps them adapt to these shortages, allowing for the administration of vital medications via alternative methods.

Specific Conservation Strategies for IV Fluids

Healthcare providers are encouraged to actively review their use of IV fluids and medications. Some of the key strategies include:

  • Assess the possibility of discontinuing IV medications for certain patients when clinically appropriate.
  • Utilize oral hydration options whenever feasible in place of IV fluids.
  • Consider alternative administration routes for medications if oral intake is not possible, such as intramuscular injections or IV push methods.
  • Prepare medications that can be administered in ready-to-use syringes to avoid wasting fluids.
  • Increase the infusion time for IV fluids when applicable.
  • And review discontinuing routine practices like keeping infusion lines open to conserve fluids.

Calling for Increased Production

Beyond managing inventory and conserving fluids, Vizient is advocating for a collective response from all IV fluid manufacturers. The call is clear: increase production and inventory levels to ensure that healthcare providers have consistent access to essential IV fluid solutions. This step is critical for maintaining patient care standards during supply chain disruptions.

Providing Resources for Healthcare Providers

To help manage these challenges effectively, Vizient has made available a valuable resource: the Adult and Pediatric IV Push Medication Reference Guide. This guide offers healthcare professionals insight into the medication alternatives available during periods of IV fluid shortages.

About Vizient, Inc.

Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company, plays an instrumental role in serving over 65% of the nation’s acute care providers. This includes a staggering 97% of the country’s academic medical centers. With a significant purchasing portfolio amounting to $140 billion, Vizient ensures the delivery of high-value, cost-effective care. Their recent acquisition of Kaufman Hall has further expanded their advisory services, helping providers navigate financial, strategic, and operational challenges and excel in healthcare delivery.

Frequently Asked Questions

What are IV fluids, and why are they crucial in healthcare?

IV fluids are essential for maintaining hydration, delivering medications, and providing nutrition to patients who cannot take fluids or food by mouth.

How can healthcare providers prepare for potential supply disruptions?

Providers should implement inventory assessments and conservation strategies, prioritize critical care areas, and review medication administration practices.

What steps should be taken if IV fluids are in short supply?

Consider alternative routes of medication administration, such as oral or intramuscular options, and use ready-to-administer syringes when possible.

How is Vizient supporting healthcare providers during the disruption?

Vizient offers guidance on inventory management and conservation strategies, providing a resource guide for healthcare providers.

What long-term impacts could this have on patient care?

Continued supply disruptions could lead to delays in treatment and affect overall patient outcomes, highlighting the need for effective management strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 15

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocky Shore Gold Completes Initial Private Placement Tranche

Updated Category News Views 118

Rocky Shore Gold Completes Initial Private Placement Tranche Rocky Shore Gold Ltd. (CSE: RSG) has successfully announced the completion of the first tranche of its non-brokered private placement, raising significant funds to support its ongoing projects. The financing initiative, which was previously publicized, demonstrates the company's commitment to advancing its...

Continue Reading
Monthly Dividend Announcement from Ellington Credit Company

Updated Category News Views 185

Ellington Credit Company Declares Monthly Dividend Ellington Credit Company (NYSE: EARN) has made an exciting announcement regarding its financial commitment to its shareholders. The company's Board of Trustees has declared a monthly common dividend, establishing an amount of $0.08 per share. This dividend will be payable shortly, offering a tangible return to those...

Continue Reading
Halide Alagoz Sells Over $1.5 Million in Ralph Lauren Shares

Updated Category News Views 128

Halide Alagoz Completes Significant Stock Sale Recent reports indicate that Halide Alagoz, the Chief Product Officer at Ralph Lauren, executed a substantial insider sale according to official filings. Details of the Insider Transaction According to regulatory disclosures, Alagoz sold 5,282 shares of Ralph Lauren, resulting in a total transaction value of approximately...

Continue Reading
Midland States Bancorp, Inc. Declares Quarterly Dividends

Updated Category News Views 86

Midland States Bancorp, Inc. Declares Quarterly Cash Dividend Midland States Bancorp, Inc. (NASDAQ: MSBI) recently announced a quarterly cash dividend of $0.31 per share for its common stock. This dividend is significant as it highlights the company’s commitment to delivering value to its shareholders. The payment will be available to shareholders of record on a...

Continue Reading
Standex International Sees Price Target Increase Amid Growth

Updated Category News Views 55

Standex International's Price Target Raised by DA Davidson Recently, Standex International (NYSE: SXI) experienced a notable increase in its price target, now set at $222.00, from analysts at DA Davidson. This update follows the company's fiscal year 2025 earnings report, coinciding with their performance in the third quarter of the calendar year. The previous price...

Continue Reading